New Orleans, LA · Health Care · Form D filed Aug 6, 2026
Quicktake Health Co. raised $2.1M
Quicktake Health Co. is a biotechnology company based in New Orleans, Louisiana. In a Form D filed with the SEC on August 6, 2026, it reported raising $2,070,000 from 5 investors as part of an offering of up to $2,070,000. The first sale in the offering took place on March 20, 2023.
Streamline vital signs measurement with contactless monitoring, automated documentation tools, and hospital kiosks for accurate patient health records.
- 2nd Form D since 2022. Earlier new notices: Dec 29, 2022. All filings on EDGAR
$2.3M raised since 2020
2 Form D offerings, as reported to the SEC, the first in Dec 29, 2022. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Aug 6, 2026 | $2.1M | $2.1M | 5 |
| Dec 29, 2022 | $220K | $500K | 6 |
Lead score
20 out of 100
early raise budget to spend website found
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Website
- quicktakehealth.com
- Amount raised
- $2,070,000
- Offering size
- $2,070,000
- Investors so far
- 5
- First sale
- March 20, 2023
- Securities offered
- Debt
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- New Orleans, Louisiana
- Incorporated
- Delaware, 2022
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $2,070,000 | $2,070,000 | 5 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Aug 3, 2026 · Raises in Louisiana · August 2026 funding report
Similar raises
Royal & Pelham, Inc.
New Orleans, LA · filed Sep 15First Form DStill raising
Trayaway, Inc.
New Orleans, LA · filed Aug 182nd Form D since 2020Still raising
Therapeutic Neuromodulation Systems LLC
Metairie, LA · filed Sep 212nd Form D since 2026Still raising
Estuary Biotherapeutics, Inc.
Menlo Park, CA · filed Oct 16First Form DStill raising
North Elam Ambulatory Surgery Center, LLC
Greensboro, NC · filed Oct 16First Form DStill raising
Immorta Bio, Inc.
Miami Beach, FL · filed Oct 162nd Form D since 2026Still raising
Lamina Surgical, Inc.
Oakland, CA · filed Oct 16
Making Open Surgery Safer | Lamina
First Form DStill raising
J3 Bioscience, Inc.
Salt Lake City, UT · filed Oct 1612th Form D since 2012